Drug fails to curb heart bypass complications, but surgery gets safer

July 10, 2012

A drug designed to shield the heart from injury during bypass surgery failed to reduce deaths, strokes and other serious events among patients at high risk of complications, according to a large, prospective study lead by researchers at Duke University Medical Center.

But the international study also produced a surprising silver lining. As reported in the July 11 issue of the , the researchers discovered that complications among patients were far less frequent than previously reported.

"We expected about 10 percent of patients were at high risk for complication following grafting," said Mark F. Newman, M.D., chairman of the Department of at Duke and lead author of the study. "But the actual risk was 5 percent. What that means is has gotten much safer, even for high-risk patients."

Newman said surgical management of patients undergoing (CABG) has improved worldwide in the past decade.

The study, which began in 2009, tested a drug called acadesine in a trial that was one of the largest involving a surgical procedure. The primary objective was to determine whether acadesine would cut the rate of complications from CABG – the most common type of open heart surgery in the United States. The procedure is highly successful in restoring blood flow to the heart caused by blockages, but strokes, ventricular damage and death can result even after successful surgery.

One cause of complications is called ischemia reperfusion injury, which stems from changes that occur to tissue starved of oxygen during the surgery, when blood vessels are clamped to establish the grafts. This period of oxygen deprivation triggers inflammation and cell once blood flow is restored.

Earlier evidence from smaller studies suggested acadesine, given before, during and after surgery, could offer protection by easing some of the inflammatory responses that kill cells. Most of those studies occurred before 1997, however, when the rate of serious complications was 10 percent or greater.

Newman and colleagues at 300 sites in seven countries randomly assigned patients to receive the trial drug or a harmless placebo, and provided followup for a month. The group found that the drug was no better than placebo at protecting people from complications, with five percent of patients having a severe event within that month regardless of taking acadesine or a mock treatment. The study, funded by the manufacturer Merck, was halted early based on a prespecified interim analysis after 3,080 patients were enrolled.

Still, the 5 percent complication rate was good news, Newman said. It is likely the result of improved surgical methods in recent years, including better anesthesia and advances in surgical and heart-lung machine management.

"A lot of things have played a part in the gradual improvement of outcomes over the years," Newman said. "We wish we had a drug that could help with ischemia/reperfusion injury – and that remains something that would benefit patients tremendously -- but we have made strides in other areas. As a result, older, sicker patients are now undergoing cardiac surgery with very good results."

Newman also said that support for publication of a negative study by the sponsor, Merck, and by the publisher JAMA, is an important step in defining the appropriate therapy for heart going forward.

Explore further: Beating heart surgery may increase risk to patients

Related Stories

Beating heart surgery may increase risk to patients

March 14, 2012
Coronary artery bypass surgery performed whilst the heart is still beating may carry an increased likelihood of death, according to a systematic review by Cochrane researchers. The researchers suggest beating heart surgery ...

Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery

January 17, 2012
Patients who discontinued use of an antiplatelet agent such as clopidogrel prior to undergoing cardiac surgery to lower their bleeding risk and received intravenously the platelet inhibitor cangrelor achieved a higher rate ...

Open heart surgery for kidney disease patients

May 17, 2012
One type of open heart surgery is likely safer than the other for chronic kidney disease (CKD) patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.